Puma Biotechnology Inc

Stock Chart, Company Information, and Scan Results

$5.28(as of Oct 1, 3:59 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Puma Biotechnology Inc Company Information, Fundamentals, and Technical Indicators

Stock Price$5.28
Ticker SymbolPBYI
ExchangeNasdaq
SectorHealthcare
IndustryBiotechnology
Employees172
CountyUSA
Market Cap$267.5M
EBIDTA57.3M
10-Day Moving Average4.80
P/E Ratio5.45
20-Day Moving Average4.72
Forward P/E Ratio3.46
50-Day Moving Average4.49
Earnings per Share1.09
200-Day Moving Average3.50
Profit Margin11.17%
RSI65.00
Shares Outstanding50.4M
ATR0.28
52-Week High6.07
Volume815,027
52-Week Low2.32
Most Recent Support Level4.37
Book Value104.7M
Most Recent Resistance Level5.33
P/B Ratio2.52
Upper Keltner5.34
P/S Ratio1.11
Lower Keltner4.10
Debt-to-Equity Ratio5.34
Next Earnings Date10/30/2025
Cash Surplus-24.4M
Next Ex-Dividend DateUnknown

Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company offers NERLYNX, an oral version of neratinib that is used to treat adult patients with early stage HER2-overexpressed/amplified breast cancer; and advanced or metastatic HER2-positive breast cancer when combined with capecitabine. It develops alisertib, a small molecule inhibitor of aurora kinase A for the treatment of hormone receptor positive breast cancer, triple negative breast cancer, small cell lung cancer, and head and neck cancer. The company sells its products through specialty pharmacy and distributor networks. It has license agreements with Pfizer Inc. for the development, manufacture, and commercialization of neratinib (oral), neratinib (intravenous), PB357, and related compounds, as well as sub-license agreements with Medison Pharma Ltd., Pint Pharma International SA, Knight Therapeutics, Inc., Pierre Fabre Medicament SAS, and Bixink Therapeutics Co., Ltd. The company was founded in 2010 and is headquartered in Los Angeles, California.

Puma Biotechnology Inc In Our Stock Scanner

As of Oct 02, 2025
example chart graphic
Scan Name: Increasing Book ValueScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: Dragonfly DojiScan Type: Candlestick Pattern Scans
As of ---
example chart graphic
Scan Name: Hammer CandleScan Type: Candlestick Pattern Scans
As of ---
example chart graphic
Scan Name: Doji CandlesScan Type: Candlestick Pattern Scans
As of ---
example chart graphic
Scan Name: Undervalued StocksScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: Low PE RatiosScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: Low PS RatioScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: Low Debt to Equity RatioScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: Increasing Profit MarginScan Type: Stock Fundamentals
As of ---

Join Our Free Email List

Get emails from us about ways to potentially make money in the stock market.

This site uses cookies to provide you with an optimal user experience. By using StockMarketGuides.com, you accept our use of cookies.